Kabra Drugs Ltd Reconstitutes Board and Committees

Kabra Drugs Ltd has announced the reconstitution of its Board of Directors and various committees, effective August 12th, 2026. The changes align with Regulation 30 of the SEBI (LODR) Regulations, 2015. The Board now includes Nanjappan Aravind as Executive Director, Managing Director & Chairperson, Kuniamuthur Nanjappan Anand as Executive Director, and Nikita Sinha, Ritu Tiwari, and Moonam Kapoor as Non-Executive Independent Directors. Key committees, including the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee, have also seen their compositions updated with specific members assigned as chairpersons and members.